Research programme: sodium glucose co-transporter inhibitors - Theratechnologies
Alternative Names: Sodium glucose co-transporter inhibitors research programme - TheratechnologiesLatest Information Update: 10 Jan 2007
At a glance
- Originator Theratechnologies
- Class
- Mechanism of Action Sodium-glucose transport protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 09 Sep 2004 Preclinical trials in Type-2 diabetes mellitus in Canada (unspecified route)